A process for stereoselective synthesis of 5-fluoro-1-(2R,5S)-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine

Details for Australian Patent Application No. 2011222471 (hide)

Owner Ranbaxy Laboratories Limited

Inventors Kshirsagar, Prakash Bhimaji; Bhoge, Satish Manohar; Richhariya, Santosh; Singh, Kaptan

Agent Callinan

Pub. Number AU-A-2011222471

PCT Pub. Number WO2011/107920

Priority 489/DEL/2010 04.03.10 IN

Filing date 25 February 2011

Wipo publication date 9 September 2011

International Classifications

C07D 411/04 Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms

Event Publications

27 September 2012 PCT application entered the National Phase

  PCT publication WO2011/107920 Priority application(s): WO2011/107920

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011222486-Aerodynamic trimmer head for use in flexible line rotary trimmers

2011222470-Process for the direct preparation of malic acid salt of sunitinib